Sagent Pharmaceuticals recalls Busulfan Injection
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications
- Products
-
- Busulfan Injection
- Company
- Sagent Pharmaceuticals
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- Lot 656412: 6,200 vials. Lot 659646: 3,328 vials.
- About this recall
- Busulfan Injection, 60 mg per 10 mL (6 mg per mL), 8x10 mL Single-Dose Vials, Rx only, Mfd. for Sagent Pharmaceuticals, Schaumburg, IL 60195, Made in Canada, NDC 25021-241-10.